The prenatal diagnosis of genetic diseases;Pränataldiagnostik genetischer erkrankungen

Deutsches Arzteblatt

Volumn 107, Issue 48, 2010, Pages 857-862

  Wieacker, Peter ^a   Steinhard, Johannes ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC ANALYSIS; GENETIC DISORDER; GENETIC SCREENING; HUMAN; NON INVASIVE PROCEDURE; PRENATAL DIAGNOSIS; REVIEW; ULTRASOUND;

CHROMOSOME DISORDERS; FEMALE; GENETIC TESTING; HUMANS; MALE; PRENATAL DIAGNOSIS;

EID: 79751474521     PISSN: 00121207     EISSN: 01722107     Source Type: Journal    
DOI: 10.3238/arztebl.2010.0857     Document Type: Review

References (23)

1. Bekanntgaben der Herausgeber: Bundesärztekammer: Richtlinien zur pränatalen Diagnostik von Krankheiten und Krankheitsdispositionen. Dtsch Arztebl 1998; 95(50): A 3238-44.
2. Hooke E: Rates of chromosome abnormalities at different maternal ages. Obstet Gynecol 1981; 58: 282-5.
3. Murken J: Pränatale Diagnostik. In: Murken J, Grimm T, Holinski-Feder E (eds.): Humangenetik. 7th edition. Stuttgart: Thieme Verlag 2006; 386-411.
4. Wald NJ, Morris JK, Walker K, Simpson JM: Prenatal screening for serious congenital heart defects using translucency: a meta-analysis. Pren Diagn 2008; 28: 1094-104.
5. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K: Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992; 304: 867-89.
6. Wald NJ, Cuckle HS, Densem JW, et al.: Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988; 297: 883-7.
7. Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG: Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Prenat Diagn 1996; 16: 143-52.
8. Bethune M: Literature review and suggested protocol for managing ultrasound soft markers for Down syndrome: thickened nuchal fold, echogenic bowel, shortened femur, shortened humerus, pyelectasis and absent or hypoplastic nasal bone. Austr Radiol 2007; 51: 218-25.
9. Nicolaides K: Some thoughts on the true value of ultrasound. Ultrasound Obstet Gynecol 2007; 30: 671-4.
10. The Online Metabolic and Molecular Bases of inherited diseases (http://www.ommbid.com/)
11. Gesetz über genetische Untersuchungen bei Menschen (Gendiagnostikgesetz - GenDG). Bundesgesetzblatt 2009; Nr. 50.
12. Jackson LG, Zachary JM, Fowler SE, et al.: A randomized comparison of transcervical and transabdominal chorionic-villus sampling. The U.S. National Institute of Child Health and Human Development Chorionic-Villus Sampling and Amniocentesis Study Group. N Engl J Med 1992; 327: 594-8.
13. Multicentre randomised clinical trial of chorion villus sampling and amniocentesis. First report. Canadian Collaborative CVS-Amniocentesis Clinical Trial Group. Lancet 1989; 1(8628): 1-6.
14. Rhoads GG, Jackson LG, Schlesselman SE, et al.: The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med 1989; 320: 609-17.
15. Medical Research Council European trial of chorion villus sampling. MRC working party on the evaluation of chorion villus sampling. Lancet 1991; 337: 1491-9.
16. Caughey AB, Hopkins LM, Norton ME: Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol 2006; 108: 612-6.
17. Merz E, Meinel K, Bals R, et al.: DEGUM-Stufe-III-Empfehlung zur "weiterführenden" sonografischen Untersuchung (= DEGUM Stufe II) im Zeitraum 11 -14 Schwangerschaftstwochen. Ultraschall in Med 2004; 25: 218-20.
18. Nicolaides KH, von Kaisenberg CS: Die Ultraschalluntersuchung von 11-13+6 Schwangerschaftswochen. London: Fetal Medicine Foundation 2004; www.fetalmedicine.com
19. Gardner RJ, Sutherland GR: Chromosome abnormalities and genetic counseling. Oxford: University Press 2004.
20. Warburton D: De novo balanced chromosome rearrangements and extra chromosomes identified at prenatal diagnosis: Clinical significance and distribution of breakpoints. Am J Hum Genet 1991; 49: 995-1013.
21. Buchholz T, Vogt U, Clement-Sengewald: Polkörperdiagnostik in Deutschland - Erfahrungen und neue Entwicklungen. J Reproduktionsmed Endokrinol 2006; 4: 215-8.
22. Aymé S, Nippert I, Marteau T and the EUROCAT working group: Variations between European regions in termination rates for fetal abnormalities: why is it so? Medgen 1999; 11: 126.
23. DADA Study Group comprising Marteau T, Nippert I, et al.: Outcomes of pregnancies diagnosed with Klinefelter syndrome: the possible influence of health professionals. Prenat Diagn 2002; 22: 562-6.